# Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke

Study · id `cardio:ct-nct03062397` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03062397](<https://clinicaltrials.gov/study/NCT03062397>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03062397

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.

## Technical summary

Registry record NCT03062397. Randomized; quadruple masking; primary purpose treatment. Start 2016-12-09 (actual); primary completion 2020-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT03062397, source copy `cardio:ctgov-nct03062397-2019-11-18`, retrieved 2026-10-26)
- Started: 2016-12-09 (actual) (ClinicalTrials.gov record NCT03062397, source copy `cardio:ctgov-nct03062397-2019-11-18`, retrieved 2026-10-26)
- Primary completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT03062397, source copy `cardio:ctgov-nct03062397-2019-11-18`, retrieved 2026-10-26)
- Completion: 2021-12 (anticipated) (ClinicalTrials.gov record NCT03062397, source copy `cardio:ctgov-nct03062397-2019-11-18`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT03062397, source copy `cardio:ctgov-nct03062397-2019-11-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03062397-2019-11-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
- Condition: Acute Ischemic Stroke
- Intervention (Drug): JPI-289 Low-dose
- Intervention (Drug): JPI-289 High-dose
- Intervention (Drug): Placebo
- Lead sponsor: Jeil Pharmaceutical Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Jeil Pharmaceutical Co., Ltd. (`cardio:org-jeil-pharmaceutical-co-ltd`)

## Provenance

Content hash: ba439372bc263d01b74ea1047437c47ab0b4dab9dd5bee9a46a6926aeb674560
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
